NCT01834950
- Conditions
- Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
- Locations
-
- Institut Gustave Roussy Villejuif, Val De Marne, France
Clinical trial condition
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
Explore clinical trials studying Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies